Brief: China Isotope & Radiation Corp Says Xofigo Developed By Bayer Officially Approved By NMPA
31/08/2020 15:54
Aug 31 (Reuters) - China Isotope & Radiation Corp 1763.HK :
* ON 27 AUG, XOFIGO DEVELOPED BY BAYER OFFICIALLY APPROVED
BY NMPA
Source text for Eikon: ID:nHKS6plg50
Further company coverage: 1763.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Isotope & Radiation
See all newsBrief: China Isotope & Radiation Corp's Unit Obatins Drug Registration Certificate For 50Mg Urea 13C Breath Test Kit
Brief: China Isotope & Radiation Proposes Appointment Of Li Penghui As Executive Director
Brief: China Isotope & Radiation Says CNGT Receives Confirmation Letter From U.S. FDA
Brief: China Isotope & Radiation Corp Says Board Approves Partnership Agreement With CNNC And Others
Brief: China Isotope & Radiation Corp Says Zhang Junqi Resigns As Executive Director